Replies to post #83184 on Biotech Values

[wallstarb]

Yeah they boo and hiss here - then the crazies come over to my site financialchat.com and bombard me with mate messages that hurt my feelings.

Technically MANY of the mid cap biotechs look horrible - MNTA isnt alone but I am noticing that many in the $600m - $5b market cap area are lookign very ugly.

AMAG - we just covered yesterday off the 200dma but take a look at the underperformance of nearly all names in that area of the market cap curve.